Question 1

What is Skye Bioscience?

Accepted Answer

Skye Bioscience is a Company.

Question 2

How often does Skye Bioscience appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 26 articles.

Question 3

When was Skye Bioscience first tracked by Ergen?

Accepted Answer

First tracked on Nov 20, 2025.

Question 4

When was Skye Bioscience last mentioned in news?

Accepted Answer

Last active on Jan 09, 2026.

Question 5

What is Skye Bioscience's current news sentiment?

Accepted Answer

Aggregate sentiment score: -55 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Skye Bioscience in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Skye Bioscience?

Accepted Answer

Skye Bioscience Class Action Lawsuit (Nov 20, 2025, 6 articles).

Question 8

How did the "Skye Bioscience Class Action Lawsuit" event impact Skye Bioscience?

Accepted Answer

Skye Bioscience is the defendant in a class action lawsuit, accused of making materially false and misleading statements regarding its business, operations, and prospects, specifically concerning the effectiveness of its drug nimacimab.

Question 9

How did the "Skye Bioscience Securities Fraud Lawsuit" event impact Skye Bioscience?

Accepted Answer

Skye Bioscience is the defendant in a class action securities lawsuit, accused of making false and misleading statements regarding the effectiveness and prospects of its lead product candidate, nimacimab. This event negatively impacts its stock price and reputation.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.